---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-095486"
form_type: "8-K"
ticker: "STRO"
cik: "0001382101"
company_name: "SUTRO BIOPHARMA, INC."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T09:59:14.989564+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Sutro Biopharma appoints Sukhi Jagpal to Board of Directors and Audit Committee

## Summary
- Sukhi Jagpal appointed as Class III director effective August 8, 2024, and to Audit Committee effective August 15, 2024.
- Jagpal receives pro rata portions of $40,000 director retainer and $10,000 Audit Committee retainer for remainder of year.
- Granted stock options: 35,000 shares (3-year monthly vest) and 28,959 shares (vesting until 2025 annual meeting).
- Standard indemnification agreement entered; no family relationships or material transactions with existing officers.

## SEC filing metadata
- accession: 0000950170-24-095486
- form_type: 8-K
- ticker: STRO
- cik: 0001382101
- company_name: SUTRO BIOPHARMA, INC.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382101/000095017024095486/0000950170-24-095486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382101/000095017024095486/stro-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-095486
- JSON: https://secwatch.observer/filing/0000950170-24-095486.json
- Plain text: https://secwatch.observer/filing/0000950170-24-095486.txt

## Key facts
- Executive change
  Sukhi Jagpal was appointed as Director at SUTRO BIOPHARMA, INC..
  - Action: appointed
  - Role: Director
  source text: On August 8, 2024, the board of directors (the “ Board ”) of Sutro Biopharma, Inc. (the “ Company ”) appointed Sukhi Jagpal, as a Class III director, effective as of August 8, 2024, and as a member of the Audit Committee, effective as of August 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382101/000095017024095486/0000950170-24-095486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.